Talampanel for Amyotrophic Lateral Sclerosis (ALS)

NCT00696332 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

559

Enrollment

INDUSTRY

Sponsor class

Conditions

ALS

Interventions

DRUG: Talampanel
DRUG: Talampanel
OTHER: placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.